Bristol-Myers Squibb Company Ownership | Who Owns Bristol-Myers Squibb Company?
Bristol-Myers Squibb Company Ownership Summary
Bristol-Myers Squibb Company is owned by 74.35% institutional investors, 0.11% insiders, and 25.53% retail investors. Vanguard group is the largest institutional shareholder, holding 9.22% of BMY shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.15% of its assets in Bristol-Myers Squibb Company shares.
BMY Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Bristol-Myers Squibb Company | 74.35% | 0.11% | 25.53% |
Sector | Healthcare Stocks | 49.73% | 8.84% | 41.43% |
Industry | Drug Manufacturers - General Stocks | 56.05% | 0.09% | 43.86% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vanguard group | 186.57M | 9.22% | $7.75B |
Blackrock | 158.66M | 7.84% | $6.59B |
State street | 91.45M | 4.52% | $3.80B |
Jpmorgan chase | 74.63M | 3.69% | $3.10B |
Charles schwab investment management | 59.06M | 2.92% | $2.45B |
Capital investors | 55.41M | 2.74% | $2.30B |
Geode capital management | 42.17M | 2.08% | $1.75B |
Fmr | 40.66M | 2.01% | $1.69B |
Norges bank | 32.59M | 1.61% | $1.35B |
Morgan stanley | 26.16M | 1.29% | $1.09B |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Birchview capital, lp | 688.22K | 26.47% | $28.58M |
Chiron capital management | 452.38K | 17.94% | $18.79M |
Sector gamma as | 535.00K | 8.30% | $22.22M |
Kahn brothers group | 827.26K | 5.77% | $34.36M |
Independent franchise partners llp | 14.60M | 5.58% | $606.36M |
Oaktop capital management ii | 679.99K | 2.89% | $28.24M |
Fulcrum asset management llp | 26.93K | 2.83% | $908.59K |
Mizuho markets americas | 2.80M | 2.79% | $116.27M |
Tamar securities | 381.09K | 2.57% | $15.83M |
Mid-american wealth advisory group | 96.66K | 2.56% | $4.01M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Norges bank | 32.59M | 0.20% | 32.59M |
Charles schwab investment management | 59.06M | 0.47% | 5.35M |
Ubs asset management americas | 16.07M | 0.19% | 3.88M |
Federated hermes | 7.55M | 0.74% | 3.50M |
Pacer advisors | 12.21M | 1.15% | 3.06M |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Capital investors | 55.41M | 0.47% | -14.80M |
Jpmorgan chase | 74.63M | 0.25% | -14.18M |
Boston partners | 3.38M | 0.17% | -7.02M |
Franklin resources | 5.78M | 0.07% | -5.80M |
Qube research | - | - | -4.69M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Norges bank | 32.59M | 0.20% | 32.59M | $1.35B |
Capital fund management | 1.68M | 0.21% | 1.68M | $69.95M |
Capital research global investors | 1.34M | 0.01% | 1.34M | $55.72M |
Susquehanna fundamental investments | 972.24K | 0.93% | 972.24K | $40.38M |
Adage capital partners gp | 871.63K | 0.07% | 871.63K | $36.20M |
Sold Out
Holder | Change |
---|---|
D.a. davidson | -1.00 |
Macroview investment management | -1.00 |
Hwg lp | -1.00 |
Tfo-tdc | -20.00 |
Ruedi wealth management | -23.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 2,292 | 4.13% | 1,507,866,452 | -1.64% | 74 | 1.30% | 1,070 | 26.48% | 890 | -14.18% |
Jun 30, 2024 | 2,162 | -9.39% | 1,529,042,503 | 0.24% | 75 | 1.33% | 830 | -23.85% | 1,020 | 6.36% |
Mar 31, 2024 | 2,386 | -1.57% | 1,525,375,313 | -1.27% | 75 | 1.35% | 1,090 | 20.58% | 959 | -20.15% |
Dec 31, 2023 | 2,424 | -0.66% | 1,544,930,196 | 0.70% | 74 | 1.34% | 904 | 2.61% | 1,201 | 2.21% |
Sep 30, 2023 | 2,440 | -3.79% | 1,534,204,662 | -3.62% | 74 | 1.29% | 881 | -16.81% | 1,175 | 11.80% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 63.98M | 3.15% | -233.02K |
Vanguard Institutional 500 Index Trust | 53.73M | 2.65% | 630.28K |
Schwab US Dividend Equity ETF™ | 51.04M | 2.52% | 62.10K |
Fidelity 500 Index | 24.92M | 1.23% | -50.64K |
SPDR® S&P 500® ETF Trust | 24.89M | 1.23% | -138.50K |
iShares Core S&P 500 ETF | 22.88M | 1.13% | 70.80K |
Vanguard Value Index Inv | 17.20M | 0.85% | 54.49K |
The Health Care Select Sector SPDR® ETF | 14.81M | 0.73% | -47.06K |
JPM US Equity Income-Composite | 14.27M | 0.70% | -313.42K |
JPMorgan Equity Income I | 14.27M | 0.70% | -80.99K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Nov 04, 2024 | Holzer Phil M | SVP and Controller | Sell | $38.93K |
Nov 01, 2024 | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | Buy | $100.06K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 1 | 1 |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q4 | 3 | - |
BMY Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools